<p>A) T98G, U87MG and Gli36ΔEGFR cells were incubated with increasing concentrations of TQ for 7–10 days. At the end of the growth period colonies were fixed, stained and counted. After taking into account the plating efficiency for each cell line, the surviving fraction is the ratio of the number of colonies counted and the initial number of cells plated. Mean ± S.D., n = 3. B) The effect of TQ on proliferation of normal human astrocytes (NHAs) compared to Gli36ΔEGFR cells was determined by a modified clonogenic assay. Cells were plated at a low density and incubated with increasing concentrations of TQ for 5 days. At the end of the growth period, cells were fixed, stained and photographed for estimation of proliferation relative to untrea...
<p>(A) Tumor volume of each treatment group during study period. 10<sup>7</sup> MDA-MB-231 cells wer...
<p>(A) A431, Hep2 and RPMI 2650 cells were treated with different concentrations of TQ or DG for 48 ...
<p>(A) Control and hUCBSC-treated glioma cells at different time points were analyzed for cell proli...
<p>U87MG and Gli36ΔEGFR cells were treated with increasing concentrations of TQ, with and without ch...
<p>(A) MTT assay of proliferation of cells treated with different concentrations of TQ and DG for 48...
<p>(<b>A</b>) Cell viability of the various cell types after 24 hour treatment with TQ at the differ...
<p>(A) SCC-4, SAS, SASVO3, OC2, and (B) S-G cells were treated with various TQ concentrations for 24...
<p>U87MG and Gli36ΔEGFR cells were incubated with increasing concentrations of CQ for 7–10 days. At ...
<p>(A) Flow cytometry–based detection of apoptotic cell death in A431 and Hep2 cells treated with a ...
<p>(Table 1) Phytochemical analysis of TCE. (<b>A</b>) MTT assay showing dose dependent decrease in ...
<p>(<b>A</b>) Morphological appearance of cells treated with TQ (50 µM) for 24 hours. (<b>B</b>) Cha...
<p>(A) Cells were incubated with 50 µM GC7 or vehicle for 48 hours. The effect of GC7 on eIF-5A hypu...
<p>Results represent quantification of n>10,000 cells for at least three substrates per condition by...
<p>Glioma cells were either TMZ or CAP treated without medium and 24 h later 150 cells/well were see...
<p>Human glioma U87MG cells (A-C) and U251MG cells (D), as well as HCN-1a neuronal cells (D) or prim...
<p>(A) Tumor volume of each treatment group during study period. 10<sup>7</sup> MDA-MB-231 cells wer...
<p>(A) A431, Hep2 and RPMI 2650 cells were treated with different concentrations of TQ or DG for 48 ...
<p>(A) Control and hUCBSC-treated glioma cells at different time points were analyzed for cell proli...
<p>U87MG and Gli36ΔEGFR cells were treated with increasing concentrations of TQ, with and without ch...
<p>(A) MTT assay of proliferation of cells treated with different concentrations of TQ and DG for 48...
<p>(<b>A</b>) Cell viability of the various cell types after 24 hour treatment with TQ at the differ...
<p>(A) SCC-4, SAS, SASVO3, OC2, and (B) S-G cells were treated with various TQ concentrations for 24...
<p>U87MG and Gli36ΔEGFR cells were incubated with increasing concentrations of CQ for 7–10 days. At ...
<p>(A) Flow cytometry–based detection of apoptotic cell death in A431 and Hep2 cells treated with a ...
<p>(Table 1) Phytochemical analysis of TCE. (<b>A</b>) MTT assay showing dose dependent decrease in ...
<p>(<b>A</b>) Morphological appearance of cells treated with TQ (50 µM) for 24 hours. (<b>B</b>) Cha...
<p>(A) Cells were incubated with 50 µM GC7 or vehicle for 48 hours. The effect of GC7 on eIF-5A hypu...
<p>Results represent quantification of n>10,000 cells for at least three substrates per condition by...
<p>Glioma cells were either TMZ or CAP treated without medium and 24 h later 150 cells/well were see...
<p>Human glioma U87MG cells (A-C) and U251MG cells (D), as well as HCN-1a neuronal cells (D) or prim...
<p>(A) Tumor volume of each treatment group during study period. 10<sup>7</sup> MDA-MB-231 cells wer...
<p>(A) A431, Hep2 and RPMI 2650 cells were treated with different concentrations of TQ or DG for 48 ...
<p>(A) Control and hUCBSC-treated glioma cells at different time points were analyzed for cell proli...